 |
|
DNA Screening for Breast/Ovarian Cancer Susceptibility Based on Linked MarkersA Family Study
Henry T. Lynch, MD;
Patrice Watson, PhD;
Theresa A. Conway, BSN;
Jane F. Lynch, BSN;
Susan M. Slominski-Caster, BSMT;
Steven A. Narod, MD;
Jean Feunteun, PhD;
Gilbert Lenoir, DVM, PhD
Arch Intern Med. 1993;153(17):1979-1987.
Abstract
| |
Background
Linkage to chromosome 17q has been identified in hereditary breast cancer and hereditary breast/ovarian cancer syndrome. A hereditary breast/ovarian cancer syndrome kindred was identified that yielded a highly significant lod score (4.20) when 17q markers were studied, enabling us to identify those who probably carried the cancerassociated gene among the high-risk members of the family.
Methods
High-risk members of the hereditary breast/ ovarian cancer syndrome kindred were offered counseling on the basis of 17q markers. Family members responding positively received one-to-one genetic counseling in a structured setting. Subjects were educated before disclosure, and the immediate impact of this information was assessed after disclosure.
Results
We provided genetic counseling on the basis of linkage findings to 32 relatives (four men and 28 women). Women who were told they were linkage positive expressed an increased motivation for surveillance and prophylactic surgery. Most women who were told they were linkage negative indicated that they would not proceed with prophylactic surgery but would continue careful surveillance. To date, there has been no evidence of serious emotional disturbances resulting from this disclosure. We believe that this experience can be used by cancer geneticists and physicians in developing protocols for genetic counseling in cancer-associated hereditary disorders.
Conclusions
Physicians must understand current developments in cancer genetics and linkage so that they can be applied to genetic counseling and treatment of high-risk patients.
(Arch Intern Med. 1993;153:1979-1987)
Author Affiliations
From the Department of Preventive Medicine/Public Health, Creighton University School of Medicine, Omaha, Neb (Drs Lynch and Watson and Mss Conway, Lynch, and Slominski-Caster); Department of Medicine, Division of Medical Genetics, Montreal (Quebec) General Hospital (Dr Narod); Laboratoire d'Oncologie Moleculaire, Institut Gustave Roussy, Villejuif, France (Dr Feunteun); and Unit of Mechanisms of Carcinogenesis, Centre International de Recherche sur le Cancer, Lyon, France (Dr Lenoir).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer
Gray et al.
J. Med. Genet. 2000;37:192-196.
ABSTRACT
| FULL TEXT
Why do women attend familial breast cancer clinics?
Brain et al.
J. Med. Genet. 2000;37:197-202.
ABSTRACT
| FULL TEXT
Can children and young people consent to be tested for adult onset genetic disorders? • Commentary: Weighing burdens and benefits rather than competence
Dickenson and Geller
BMJ 1999;318:1063-1066.
FULL TEXT
Attitudes and Interest in Genetic Testing for Breast and Ovarian Cancer Susceptibility in Diverse Groups of Women in Western Washington
Durfy et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:369-375.
ABSTRACT
| FULL TEXT
The new genetics: Psychological responses to genetic testing
Marteau and Croyle
BMJ 1998;316:693-696.
FULL TEXT
Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent
Geller et al.
JAMA 1997;277:1467-1474.
ABSTRACT
Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: II. BRCA1 and BRCA2
Burke et al.
JAMA 1997;277:997-1003.
ABSTRACT
BRCA1 Testing in Families With Hereditary Breast-Ovarian Cancer: A Prospective Study of Patient Decision Making and Outcomes
Lerman et al.
JAMA 1996;275:1885-1892.
ABSTRACT
Coming to Terms with the Risk of Breast Cancer: Perceptions of Women with Primary Relatives with Breast Cancer
Chalmers and Thomson
Qual Health Res 1996;6:256-282.
ABSTRACT
A positive screening test for an untreatable condition provides psychological relief from uncertainty
Marteau and Michie
BMJ 1995;311:58c-59.
FULL TEXT
Phenotypic Variation in Hereditary Breast Cancer: Cancer Control Implications
Lynch et al.
Arch Surg 1994;129:806-813.
ABSTRACT
|
